The changes within the pharmaceutical industry show no signs of abating as financial pressures – whether from the decline of the traditional blockbuster or the rise of cost-containment measures – press down on companies.
The changes within the pharmaceutical industry show no signs of abating as financial pressures – whether from the decline of the traditional blockbuster or the rise of cost-containment measures – press down on companies.